Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
West Pharmaceutical Services, Inc. (WST) had Pre-Tax Income of $600.90M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.07B |
|
$493.70M |
|
$1.97B |
|
$1.10B |
|
$2.49B |
|
$584.90M |
|
$16.00M |
|
|
Pre-Tax Income |
$600.90M |
$600.90M |
|
$479.30M |
|
$493.70M |
|
$493.70M |
|
$479.30M |
|
$584.90M |
|
$756.30M |
|
72.30M |
|
72.70M |
|
$6.83 |
|
$6.79 |
|
| Balance Sheet Financials | |
$1.98B |
|
$1.73B |
|
$2.29B |
|
$4.27B |
|
$654.90M |
|
$202.80M |
|
$439.10M |
|
$1.09B |
|
$3.18B |
|
$3.06B |
|
$3.18B |
|
72.00M |
|
| Cash Flow Statement Financials | |
$754.80M |
|
$-285.90M |
|
$-185.10M |
|
$484.60M |
|
$791.30M |
|
$306.70M |
|
$23.80M |
|
$-61.20M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.02 |
|
-- |
|
-- |
|
0.06 |
|
0.06 |
|
35.91% |
|
19.03% |
|
19.03% |
|
24.60% |
|
19.55% |
|
16.06% |
|
$468.90M |
|
-- |
|
-- |
|
-- |
|
0.72 |
|
4.44 |
|
5.35 |
|
68.20 |
|
15.54% |
|
16.14% |
|
11.56% |
|
14.61% |
|
$44.11 |
|
$6.45 |
|
$10.38 |
|